Metropolitan Life Insurance CO Chinook Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$18.66 - $38.58 $7,930 - $16,396	425 Added 15.49%	3,169 $121,000
Q1 2023 May 15, 2023	SELL	$21.53 - $26.8 $5,597 - $6,968	-260 Reduced 8.66%	2,744 $63,000
Q4 2022 Jun 14, 2023	BUY	$18.63 - $27.35 $4,843 - $7,111	260 Added 9.48%	3,004 $78.7 Million
Q3 2022 Jun 14, 2023	BUY	$17.51 - $23.37 $4,552 - $6,076	260 Added 9.48%	3,004 $59.1 Million
Q3 2022 Mar 30, 2023	BUY	$17.51 - $23.37 $6,146 - $8,202	351 Added 13.23%	3,004 $59,000
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $6,146 - $8,202	351 Added 13.23%	3,004 $59,000
Q2 2022 Jun 20, 2023	SELL	$12.59 - $18.8 $1,145 - $1,710	-91 Reduced 3.32%	2,653 $46,000
Q2 2022 Mar 30, 2023	BUY	$12.59 - $18.8 $4,935 - $7,369	392 Added 17.34%	2,653 $46,000
Q2 2022 Aug 11, 2022	BUY	$12.59 - $18.8 $4,935 - $7,369	392 Added 17.34%	2,653 $46,000
Q1 2022 Jun 20, 2023	SELL	$12.02 - $16.69 $5,805 - $8,061	-483 Reduced 17.6%	2,261 $36,000
Q1 2022 Mar 30, 2023	SELL	$12.02 - $16.69 $88,010 - $122,204	-7,322 Reduced 76.41%	2,261 $36,000
Q1 2022 May 12, 2022	SELL	$12.02 - $16.69 $88,010 - $122,204	-7,322 Reduced 76.41%	2,261 $37,000
Q4 2021 Jun 21, 2023	BUY	$10.69 - $16.83 $73,108 - $115,100	6,839 Added 249.23%	9,583 $156,000
Q3 2021 Jun 21, 2023	BUY	$11.5 - $14.86 $78,648 - $101,627	6,839 Added 249.23%	9,583 $122,000
Q2 2021 Jun 21, 2023	BUY	$13.6 - $18.98 $93,010 - $129,804	6,839 Added 249.23%	9,583 $135,000
Q2 2021 Mar 30, 2023	BUY	$13.6 - $18.98 $69,088 - $96,418	5,080 Added 112.81%	9,583 $135,000
Q2 2021 Aug 16, 2021	BUY	$13.6 - $18.98 $130,328 - $181,885	9,583 New	9,583 $135,000
Q1 2021 May 14, 2021	SELL	$14.17 - $19.11 $63,807 - $86,052	-4,503 Closed	0 $0
Q4 2020 Jun 22, 2023	BUY	$11.9 - $20.91 $20,932 - $36,780	1,759 Added 64.1%	4,503 $71,000
Q4 2020 Mar 30, 2023	BUY	$11.9 - $20.91 $17,838 - $31,344	1,499 Added 49.9%	4,503 $71,000
Q4 2020 Feb 16, 2021	BUY	$11.9 - $20.91 $53,585 - $94,157	4,503 New	4,503 $71,000

Others Institutions Holding KDNY

# of Institutions

Shares Held

234K

Call Options Held

Put Options Held

View Full List

About CHINOOK THERAPEUTICS, INC.

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

More about KDNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account